相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Can successful treatment by direct-acting antivirals improve depression in chronic HCV patients?
Amal Tohamy Abdel Moez et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B
Hye Won Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans Population
Urbano Sbarigia et al.
ADVANCES IN THERAPY (2020)
Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis
Baohui Fu et al.
PLOS ONE (2020)
Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
Cristina Maria Muzica et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals
Riccardo Nevola et al.
JGH OPEN (2020)
Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment
Mostafa Elhelbawy et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Effectiveness of direct-acting agents for hepatitis C and liver stiffness changing after sustained virological response
Flavia F. Fernandes et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review
C. Mazzaro et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Rising Trends in Emergency Department Visits Associated With Hepatitis C Virus Infection in the United States, 2006-2014
Shaoman Yin et al.
PUBLIC HEALTH REPORTS (2019)
What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
George N. Ioannou et al.
GASTROENTEROLOGY (2019)
Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response
Ryoko Yamada et al.
HEPATOLOGY RESEARCH (2019)
Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy
Arash Vaziri et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virus
Takako Inoue et al.
HEPATOLOGY RESEARCH (2018)
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents
Alessia Ciancio et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy
T. Tada et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study
A. W. Singer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon et al.
GASTROENTEROLOGY (2018)
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2018)
Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs
Ghada El Sagheer et al.
LIBYAN JOURNAL OF MEDICINE (2018)
Inpatient hospital burden of hepatitis C-diagnosed patients with decompensated cirrhosis
Scott A. McDonald et al.
LIVER INTERNATIONAL (2018)
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting
Giovanni Perricone et al.
LIVER INTERNATIONAL (2018)
Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication - comparison of the new direct-acting antiviral agents with the old regimens
Joana Rita Carvalho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes
Patrice Cacoub et al.
VALUE IN HEALTH (2018)
Impact of Direct Acting Antiviral (DAA) Treatment on Glucose Metabolism and Reduction of Pre-diabetes in Patients with Chronic Hepatitis C
Philip Weidner et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2018)
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
Tien S. Dong et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis
F. Mettke et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
P. Schwabl et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon et al.
GASTROENTEROLOGY (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
Increasing Burden of Liver Cancer Despite Extensive Use of Antiviral Agents in a Hepatitis B Virus-Endemic Population
Jonggi Choi et al.
HEPATOLOGY (2017)
The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B
George V. Papatheodoridis et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience
Shereen Abdel Alem et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis
Masako Okada et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Prevalence and Economic Burden of Extrahepatic Manifestations of Hepatitis C Virus Are Underestimated But Can Be Improved With Therapy
Nancy Reau et al.
HEPATOLOGY COMMUNICATIONS (2017)
Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients
D. Lin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
The role of liver progenitor cells during liver regeneration, fibrogenesis, and carcinogenesis
Julia Koehn-Gaone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Hepatitis B Virus Infection and Liver Decompensation
Brendon K. Luvisa et al.
CLINICS IN LIVER DISEASE (2016)
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies
Salvatore Petta et al.
GASTROENTEROLOGY (2016)
Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden
Zobair Younossi et al.
GASTROENTEROLOGY (2016)
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
Luca Saverio Belli et al.
JOURNAL OF HEPATOLOGY (2016)
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
Mattias Mandorfer et al.
JOURNAL OF HEPATOLOGY (2016)
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
Michelle C. M. Cheung et al.
JOURNAL OF HEPATOLOGY (2016)
Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment
Satoru Hashimoto et al.
PLOS ONE (2016)
Effect of Nucleoside and Nucleotide Analogues on Renal Function in Patients With Chronic Hepatitis B Virus Monoinfection
Vincent Mallet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Hepatitis C Virus A European Perspective
Georg Dultz et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2015)
Effect of Sofosbuvir and Ribavirin Treatment on Peripheral and Hepatic Lipid Metabolism in Chronic Hepatitis C Virus, Genotype 1-Infected Patients
Eric G. Meissner et al.
HEPATOLOGY (2015)
Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis
Jeong Won Jang et al.
HEPATOLOGY (2015)
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2015)
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort
G. V. Papatheodoridis et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
Young-Suk Lim et al.
GASTROENTEROLOGY (2014)
Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B-A Nationwide Cohort Study
Chun-Ying Wu et al.
GASTROENTEROLOGY (2014)
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
Jessica Liu et al.
GUT (2014)
High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
E. Cholongitas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B
Bingliang Lin et al.
HEPATOLOGY INTERNATIONAL (2013)
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis
Takashi Kumada et al.
JOURNAL OF HEPATOLOGY (2013)
Reactivation of Hepatitis B Virus in Patients With Undetectable HBsAg Undergoing Chemotherapy for Malignant Lymphoma or Multiple Myeloma
Takeshi Matsui et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Alla Arzumanyan et al.
NATURE REVIEWS CANCER (2013)
Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents
Chang Ha Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
Cheng-Yuan Peng et al.
JOURNAL OF HEPATOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study
George V. Papatheodoridis et al.
GUT (2011)
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Efficacy and Safety of Entecavir Versus Adefovir in Chronic Hepatitis B Patients With Hepatic Decompensation: A Randomized, Open-Label Study
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Tenofovir Improves the Outcome in Patients with Spontaneous Reactivation of Hepatitis B Presenting as Acute-On-Chronic Liver Failure
Hitendra Garg et al.
HEPATOLOGY (2011)
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma
Michael C. Kew
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction
Gene G. Hunder et al.
ARTHRITIS AND RHEUMATISM (2010)
Clearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma in a Cohort Chronically Infected with Hepatitis B Virus
Josephine Simonetti et al.
HEPATOLOGY (2010)
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis
Kausik Das et al.
LIVER INTERNATIONAL (2010)
Predictors of health-related quality of life in patients with chronic liver disease
A. Afendy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis
Myron John Tong et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma
Makoto Chuma et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Natural history of hepatitis-related hepatocellular carcinoma
David Yiu-Kuen But et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection
Jillian Kallman et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Hepatitis B virus genotypes and extrahepatic manifestations
P Cacoub et al.
JOURNAL OF HEPATOLOGY (2005)
Hepatitis B virus-associated polyarteritis Nodosa - Clinical characteristics, outcome, and impact of treatment in 115 patients
L Guillevin et al.
MEDICINE (2005)
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
JOURNAL OF VIRAL HEPATITIS (2004)
Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation
AY Hui et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
分享论文
